Some NBS programs for Pompe disease, including ours, have shown that the combination of GAA enzyme assays using dried-blood spot (DBS) cards and GAA gene mutation analysis could be useful in distinguishing false-positive cases from patients with Pompe disease. Here, GAA is linked to glycogen storage disease II.